The Role of Interleukin-6 in Castleman Disease

Authors

Keywords

Interleukin-6, Humanized anti-IL-6 receptor antibody, Tocilizumab, Chimeric anti-IL-6 antibody, Siltuximab, Multicentric Castleman disease, IL-6 blocking therapy

Journal

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Volume 32, Issue 1, Pages 23-36

Publisher

Elsevier BV

Online

2017-11-18

DOI

10.1016/j.hoc.2017.09.003

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now